Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on April 21, 2025
Trusted from London to Toronto: XBTDirect Becomes the Go-To Platform for Smart Traders
GlobeNewswire
·
April 21, 2025
London, UK, April 21, 2025 (GLOBE NEWSWIRE) -- As traders across the globe seek faster, safer, and more transparent platforms, XBTDirect has quickly positioned itself as the preferred choice for serious investors in both the United Kingdom and Canada. With …
GivBux, Inc. Finalizes Terms of Special Warrant Dividend for Shareholders
GlobeNewswire
·
April 21, 2025
Newport Beach, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- GivBux, Inc. (OTC: GBUX) ("GivBux" or the Company"), a publicly traded Super App and charitable giving platform, today announced the finalized terms of its previously approved special dividend for …
Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development
GlobeNewswire
·
April 21, 2025
AUSTIN, Texas, April 21, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company focused on developing novel, investigational treatments, including simufilam, for central nervous …
Achieve financial freedom potential with RICH MINER Cloud Mining Platform
GlobeNewswire
·
April 21, 2025
London, UK, April 21, 2025 (GLOBE NEWSWIRE) -- Recently, RICH MINER announced its latest development plan in the field of mineral resources, aiming to push the mining industry to new heights through technological innovation and sustainable development …
Revive Therapeutics Announces Proposed Shares for Debt Transaction
GlobeNewswire
·
April 21, 2025
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, …
TruGolf Reports 2024 Financial Results
GlobeNewswire
·
April 21, 2025
Salt Lake City, Utah, April 21, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading provider of golf simulator software and hardware, announced today an overview of its 2024 results that were filed on Form 10-K on April 15, 2025. The …
ESCO Technologies Announces Second Quarter 2025 Earnings Release and Conference Call
GlobeNewswire
·
April 21, 2025
St. Louis, April 21, 2025 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE:ESE) will report its second quarter financial results after the market close on Wednesday, May 7, 2025, followed by a conference call where the financial results and related …
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
GlobeNewswire
·
April 21, 2025
GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Galapagos Announces Executive Leadership Updates
GlobeNewswire
·
April 21, 2025
Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as founding CEO of newly created SpinCo Dr. Paul Stoffels, Chair and CEO of Galapagos, plans to retire as CEO upon appointment of successor in the next 12 months and plans to continue as …
Galapagos kondigt wijzigingen aan in uitvoerend leiderschap
GlobeNewswire
·
April 21, 2025
De heer Henry Gosebruch benoemd door de Raad van Bestuur van Galapagos als oprichtend CEO van het nieuw opgerichte SpinCo Dr. Paul Stoffels, Voorzitter en CEO van Galapagos, is van plan in pensioen te gaan als CEO na benoeming van een opvolger in de …
Bringing clarity and precision to the cell-free space by introducing exozymes
GlobeNewswire
·
April 21, 2025
Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paper The author team introduces the terms ‘exozymes’ to bring clarity to the rapidly evolving field of cell-free biomanufacturing—a …
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
GlobeNewswire
·
April 21, 2025
IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications …
Regeneron Announces Investor Conference Presentations
GlobeNewswire
·
April 21, 2025
TARRYTOWN, N.Y., April 21, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: BofA Securities 2025 Health Care Conference at 10:00 a.m. PT (1:00 p.m. ET) on Tuesday, May 13, 2025 2025 …
Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing
GlobeNewswire
·
April 21, 2025
SALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced that the Journal of Clinical Psychopharmacology has published a study showing those …
Kaltura to Announce Financial Results for First Quarter 2025 on Thursday, May 8, 2025
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Kaltura (Nasdaq: KLTR), the Video Experience Cloud, today announced it will release its first quarter financial results for the period ended March 31, 2025, before market open on Thursday, May 8, 2025. …
Climb Global Solutions Appoints Paul Giovacchini to its Board of Directors
GlobeNewswire
·
April 21, 2025
EATONTOWN, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, today …
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025
GlobeNewswire
·
April 21, 2025
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of …
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism
GlobeNewswire
·
April 21, 2025
The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate for treating ASD in 2026 BOSTON, April 21, 2025 ( …
AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer
GlobeNewswire
·
April 21, 2025
IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications …
CarGurus To Report First Quarter 2025 Financial Results
GlobeNewswire
·
April 21, 2025
BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, announced it will issue a press release reporting financial results for the quarter …